fenoldopam has been researched along with Goldblatt Syndrome in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Excerpt | Relevance | Reference |
---|---|---|
"To determine the effects of dopamine-1 agonist therapy in severe hypertension, blood pressure, heart rate, catecholamines and left ventricular function were studied in 18 patients (10 with renal disease) with diastolic blood pressure greater than 120 mm Hg (range 124 to 160) after intravenous fenoldopam therapy." | 7.67 | Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. ( Gonzalez, FM; Katz, AM; McCabe, EJ; Radford, MJ; Weed, SG; White, WB, 1988) |
"To determine the effects of dopamine-1 agonist therapy in severe hypertension, blood pressure, heart rate, catecholamines and left ventricular function were studied in 18 patients (10 with renal disease) with diastolic blood pressure greater than 120 mm Hg (range 124 to 160) after intravenous fenoldopam therapy." | 3.67 | Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. ( Gonzalez, FM; Katz, AM; McCabe, EJ; Radford, MJ; Weed, SG; White, WB, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
White, WB | 1 |
Radford, MJ | 1 |
Gonzalez, FM | 1 |
Weed, SG | 1 |
McCabe, EJ | 1 |
Katz, AM | 1 |
1 other study available for fenoldopam and Goldblatt Syndrome
Article | Year |
---|---|
Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam.
Topics: Adult; Aged; Benzazepines; Blood Pressure; Diuresis; Dopamine Antagonists; Drug Administration Sched | 1988 |